HK1148204A1 - Radiotherapy enhancer - Google Patents

Radiotherapy enhancer

Info

Publication number
HK1148204A1
HK1148204A1 HK11102327.7A HK11102327A HK1148204A1 HK 1148204 A1 HK1148204 A1 HK 1148204A1 HK 11102327 A HK11102327 A HK 11102327A HK 1148204 A1 HK1148204 A1 HK 1148204A1
Authority
HK
Hong Kong
Prior art keywords
radiotherapy enhancer
radiotherapy
enhancer
Prior art date
Application number
HK11102327.7A
Other languages
English (en)
Inventor
Masakazu Fukushima
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of HK1148204A1 publication Critical patent/HK1148204A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK11102327.7A 2005-04-01 2011-03-08 Radiotherapy enhancer HK1148204A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005105819 2005-04-01

Publications (1)

Publication Number Publication Date
HK1148204A1 true HK1148204A1 (en) 2011-09-02

Family

ID=37073533

Family Applications (2)

Application Number Title Priority Date Filing Date
HK08109852.0A HK1118704A1 (en) 2005-04-01 2008-09-04 Radiotherapy enhancer
HK11102327.7A HK1148204A1 (en) 2005-04-01 2011-03-08 Radiotherapy enhancer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK08109852.0A HK1118704A1 (en) 2005-04-01 2008-09-04 Radiotherapy enhancer

Country Status (12)

Country Link
US (3) US20080275071A1 (xx)
EP (1) EP1864683B1 (xx)
JP (1) JP4956423B2 (xx)
KR (1) KR101065932B1 (xx)
CN (2) CN101912399B (xx)
AU (1) AU2006231808B2 (xx)
CA (1) CA2603809C (xx)
DE (1) DE602006016576D1 (xx)
ES (1) ES2348996T3 (xx)
HK (2) HK1118704A1 (xx)
TW (1) TWI434700B (xx)
WO (1) WO2006106983A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101135789B1 (ko) * 2005-04-01 2012-04-16 다이호야쿠힌고교 가부시키가이샤 피리딘 유도체를 유효성분으로 하는 방사선 치료 증강제
ES2671926T3 (es) * 2011-05-25 2018-06-11 Taiho Pharmaceutical Co., Ltd. Comprimido recubierto en seco que contiene tegafur, gimeracilo y oteracilo potásico
US9877966B1 (en) * 2015-08-10 2018-01-30 Eugene J. Oliva Combination therapy for the inhibition of metastasis and tumorigenesis
CN106692173A (zh) * 2015-11-18 2017-05-24 北京诺普德医药科技有限公司 一种抗肿瘤复方组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62155215A (ja) 1984-11-30 1987-07-10 Otsuka Pharmaceut Co Ltd 抗腫瘍活性増強剤
AU654555B2 (en) * 1991-05-27 1994-11-10 Taiho Pharmaceutical Co., Ltd. Composition, method and kit for potentiating antitumor activity and for curing tumor
US5565478A (en) * 1994-03-14 1996-10-15 The United States Of America As Represented By The Department Of Health & Human Services Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
US20040265813A1 (en) * 2001-07-05 2004-12-30 Teiji Takechi Dna arrays for measuring sensitivity to anticancer agent
US9611227B2 (en) * 2003-03-14 2017-04-04 Taiho Pharmaceutical Co., Ltd. Antitumor effect potentiator and antitumor agent
JP4994618B2 (ja) * 2005-08-11 2012-08-08 学校法人北里研究所 Ｔｓ−１／カンプトテシン類による化学放射線療法
US8198264B2 (en) * 2006-04-28 2012-06-12 National Cancer Center Method for treating head and neck cancer

Also Published As

Publication number Publication date
JPWO2006106983A1 (ja) 2008-09-25
KR101065932B1 (ko) 2011-09-19
TWI434700B (zh) 2014-04-21
CN101912399B (zh) 2012-05-23
US20080275071A1 (en) 2008-11-06
DE602006016576D1 (de) 2010-10-14
US20090281105A1 (en) 2009-11-12
HK1118704A1 (en) 2009-02-20
CA2603809A1 (en) 2006-10-12
CN101155600A (zh) 2008-04-02
AU2006231808A1 (en) 2006-10-12
WO2006106983A1 (ja) 2006-10-12
US20130101680A1 (en) 2013-04-25
JP4956423B2 (ja) 2012-06-20
AU2006231808B2 (en) 2010-06-24
KR20080000628A (ko) 2008-01-02
CA2603809C (en) 2011-12-06
TW200716180A (en) 2007-05-01
CN101155600B (zh) 2011-05-04
EP1864683B1 (en) 2010-09-01
EP1864683A4 (en) 2008-12-24
CN101912399A (zh) 2010-12-15
EP1864683A1 (en) 2007-12-12
ES2348996T3 (es) 2010-12-21

Similar Documents

Publication Publication Date Title
HK1205935A1 (en) Non-lithotripsic kidney-stone therapy
EP2030513A4 (en) SALT TASTE AMPLIFIERS
EP1917997A4 (en) RADIATION THERAPY DEVICE
ZA200709615B (en) Pyrrolobenzodiazepines
EP1960247A4 (en) TRAILER
ZA200808747B (en) Fertilizer
ZA200804149B (en) Smoke enhancer
GB0504206D0 (en) Combination therapy
GB0509052D0 (en) Combination therapy
ZA200709627B (en) Combination therapy
HK1148204A1 (en) Radiotherapy enhancer
GB2429046B (en) Trailers
GB2423754B (en) Ground-loading trailer
ZA200708177B (en) Fertilizer
GB0516484D0 (en) Trailers
GB0517798D0 (en) Enhancer elements
GB0522746D0 (en) Pyrrolobenzodiazepines
GB0509559D0 (en) Improved trailers
GB0503064D0 (en) Trailer improvements
GB0503063D0 (en) Trailer improvements
GB0503065D0 (en) Trailer improvements
ZAA200500359S (en) Trailers
GB0507826D0 (en) Trailers
GB0515341D0 (en) Trailer
AU316716S (en) Swimwear - one piece